Nine novel growth hormone receptor gene mutations in patients with Laron syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 2, 1997, Pages 435-437

  Sobrier, Marie Laure ^a   Dastot, Florence ^a   Duquesnoy, Philippe ^a   Kandemir, Nurgün ^b   Yordam, Nursen ^b   Goossens, Michel ^a   Amselem, Serge ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE RECEPTOR;

ARTICLE; CELL PROLIFERATION; DRUG RECEPTOR BINDING; GENE DELETION; GENE MUTATION; GROWTH HORMONE DEFICIENCY; HORMONE BINDING; HUMAN; HUMAN CELL; LARON SYNDROME; MISSENSE MUTATION; NONSENSE MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; RECEPTOR GENE; SOLUBILIZATION;

BASE SEQUENCE; DRUG RESISTANCE; EXONS; GENES; HUMAN GROWTH HORMONE; HUMANS; MUTATION; RECEPTORS, SOMATOTROPIN; SYNDROME;

EID: 0031032355     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.2.435     Document Type: Article

References (26)

1. Isaksson OGP, Eden S, Jansson J-O.1985 Mode of action of pituitary growth hormone on target cells. Annu Rev Physiol. 47:483-499.
2. Godowski PJ, Leung DW, Meacham LR, et al. 1989 Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism. Proc Natl Acad Sci USA. 86:8083-8087.
3. Pekhletsky RI, Chernov BK, Rubtsov PM. 1992 Variants of the 5′-untranslated sequence of human growth hormone receptor mRNA. Mol Cell Endocrinol. 90:103-109.
4. Leung DW, Spencer SA, Cachianes G, et al. 1987 Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature. 330:537-543.
5. Carter-Su C, Schwartz J, Smit LS. 1996 Molecular mechanism of growth hormone action. Annu Rev Physiol. 58:187-207.
6. Wells JA, De Vos AM. 1996 Hematopoitic receptor complexes. Annu Rev Biochem. 65:609-634.
7. Veldhuis J, Johnson M, Faunt L, Mercado M, Baumann G. 1993 Influence of the high affinity growth hormone (GH)-binding protein on plasma profiles of free and bound GH and on apparent half-life of GH. J Clin Invest. 91:629-641.
8. Amselem S, Sobrier M-L, Dastot F, Duquesnoy P, Duriez B, Goossens M. 1996 Molecular basis of inherited growth hormone resistance in childhood. In: Ross RJM, Savage MO, eds. Clinical endocrinology and metabolism. Growth hormone resistance 10(3). London: Bailliere's; 353-370.
9. Laron Z, Pertzelan A, Karp M, Kowadlo-Silbergeld A, Daughaday WH. 1971 Administration of growth hormone to patients with familial dwarfism with high plasma immunoreactive growth hormone: measurement of sulfation factor, metabolic and linear growth response. J Clin Endocrinol Metab. 33:332-342.
10. Amselem S, Duquesnoy P, Attree O, et al. 1989 Laron dwarfism and mutations of the growth hormone-receptor gene. N Engl J Med. 321:989-995.
11. Amselem S, Sobrier M-L, Duquesnoy P, et al. 1991 Recurrent nonsense mutations in the growth hormone receptor from patients with Laron dwarfism. J Clin Invest. 87:1098-1102.
12. Berg MA, Guevara-Aguirre J, Rosenbloom AL, Rosenfeld RG, Franke U. 1992 Mutation creating a new splice site in the growth hormone receptor genes of 37 Ecuadorean patients with Laron syndrome. Human Mutation. 1:24-34.
13. Amselem S, Duquesnoy P, Duriez B, et al. 1993 Spectrum of growth hormone receptor mutations and associated haplotypes in Laron syndrome. Hum Mol Genet. 2:355-359.
14. Berg M, Argente J, Chernausek S, et al. 1993 Diverse growth hormone receptor gene mutations in Laron syndrome. Am J Hum Genet. 52:998-1005.
15. Berg MA, Peoples R, Perez-Jurado L, et al. 1994 Receptor mutations and haplotypes in growth hormone receptor deficiency: a global survey and identification of the Ecuadorean E180splice mutation in an oriental Jewish patient. Acta Paediatr. 83:112-114.
16. Laron Z, Klinger B, Eshet R, Kaneti H, Karasik A, Silbergeld A. 1993 Laron syndrome due to a post-receptor defect: response to IGF-I treatment. Isr J Med Sci. 29:757-763.
17. Woods K, Camacho-Hübner C, Clark A, Savage M. Homozygous partial IGF-1 gene deletion in a patient with intrauterine growth retardation and postnatal growth failure. Program of 35th Annual Meeting of the European Society Pediatric Endocrinology, 1996, Montpelier, France, (Abstract 22).
18. Duquesnoy P, Sobrier ML, Duriez B, et al. 1994 A single amino acid substitution in the exoplasmic domain of the human growth hormone (GH) receptor confers familial GH resistance (Laron-Syndrome) with positive GH-binding activity by abolishing receptor homodimerization. EMBO J. 13:1386-1395.
19. Woods KA, Fraser NC, Postel-Vinay M-C, Savage MO, Clark AJL. 1996 A homozygous splice site mutation affecting the intracellular domain of the growth hormone (GH) receptor resulting in Laron syndrome with elevated GH-binding protein. J Clin Endocrinol Metab. 81:1686-90.
20. Blum WF, Cotterill AM, Postel-Vinay MC, et al. 1994 Improvement of diagnostic criteria in growth hormone insensitivity syndrome: solutions and pitfalls. Acta Paediatr. 83:117-124.
21. Meacham LR, Brown MR, Murphy TL, et al. 1993 Characterization of a noncontiguous gene deletion of the growth hormone receptor in Laron's syndrome. J Clin Endocrinol Metab. 77:1379-1383.
22. Gyllensten UB, Erlich HA. 1988 Generation of single-strand DNA by the polymerase chain reaction and its application to direct sequencing of HLA-DQA locus. Proc Natl Acad Sci USA. 85:7652-7656.
23. Krawczak M, Reiss J, Cooper DN. 1992 The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet. 90:41-54.
24. Ohshima Y, Gotoh Y. 1987 Signals for the selection of a splice site in pre-mRNA-computer analysis of splice junction sequences and like sequences. J Mol Biol. 195:247-259.
25. Schiavi A, Bartlett R, Brown M, et al. 1995 Preferential transcription from an activated cryptic splice site results in aberrant mRNA processing and protein truncation in a Bahamian genetic isolate of Laron syndrome. The University of Chicago Press, Annual Meeting of the American Society of Human Genetics, Minneapolis, 1995, p 227 (Abstract).
26. De Vos AM, Ultsch M, Kossiakoff A. 1992 Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science. 255:306-312.